← FDA DRUG APPROVALS

FDA ANDA · ANDA081266

METHYLPREDNISOLONE SODIUM SUCCINATE

Sponsor: TEVA PARENTERAL

APPLICATION
ANDA081266
TYPE
ANDA
ORIGINAL APPROVAL
1992-11-30
LATEST ACTION
1993-11-12
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METHYLPREDNISOLONE SODIUM SUCCINATEDiscontinued
METHYLPREDNISOLONE SODIUM SUCCINATE EQ 125MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

1993-11-12Labeling · Supplement 1AP
1992-11-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →